Global Cord Blood Corporation filings document the company's status as a foreign private issuer and the court-supervised provisional liquidation process ordered by the Grand Court of the Cayman Islands in 2022. Recent Form 6-K reports furnish joint provisional liquidator reports and describe Exchange Act current-report disclosures, Form 20-F issuer status, and continuing corporate-status reporting.
Global Cord Blood Corporation filed an update as a foreign private issuer describing the latest developments in its court-supervised provisional liquidation process in the Cayman Islands. The Grand Court previously appointed joint provisional liquidators (JPLs) for the company under the Cayman Companies Act.
On March 2, 2026, the JPLs submitted their fifteenth report to the Grand Court. The report is available to stakeholders on the company’s investor relations website and on Grant Thornton’s creditor update page. The filing also lists the dates of all prior JPL reports since October 2022, highlighting an ongoing series of structured status updates for creditors and other interested parties.
Global Cord Blood Corporation reports that its court-appointed joint provisional liquidators have submitted their fourteenth report to the Grand Court of the Cayman Islands. The liquidators were originally appointed on September 22, 2022 under the Cayman Islands Companies Act to oversee the Company’s affairs during provisional liquidation.
The new report, dated December 1, 2025, is available to the public on the Company’s investor relations website and on Grant Thornton’s creditor update page. The Company also notes that earlier reports from October 2022 through September 2025 remain accessible, providing an ongoing record of developments in the provisional liquidation process.